Can middle income countries catch up in cancer treatment?

Our aim in this paper is to set out some realistic options for improving cancer treatment in middle income countries. Most discussion has focused on prevention with less attention to the actual service options open to such countries (in the income range $4-10,000 per head). We would support a strong emphasis on prevention but we see service as a complementary priority. Better access to effective treatment will increase the incentives to adopt preventive approaches.